Hipertensión y Riesgo Vascular

Sugerencias
Hipertensión y Riesgo Vascular Detección de hipertrofia ventricular izquierda en adolescentes con hipertensió...
Información de la revista
Vol. 23. Núm. 9.
Páginas 275-322 (Diciembre 2006)
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Vol. 23. Núm. 9.
Páginas 275-322 (Diciembre 2006)

Detección de hipertrofia ventricular izquierda en adolescentes con hipertensión arterial esencial

Detection of left ventricular hypertrophy in adolescents with essential arterial hypertension
Visitas
7890
M. Ramírez Méndez†,a, F.L. Moreno-Martínezb, D. Torres Ruiza, C.G. Nieto Monteagudoa, C.M. Osorio Gómezb, A. Guevara Gonzálezc, A. González Díazb, R. González Chineab
a Hospital Universitario Celestino Hernández Robau. Santa Clara
b Cardiocentro Ernesto Che Guevara. Santa Clara
c Centro de Investigaciones sobre Longevidad, Envejecimiento y Salud (CITED). Ciudad de La Habana. Cuba
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Introducción

La hipertensión arterial (HTA) constituye un problema de salud mundial y su riesgo depende de los órganos que sea capaz de dañar. La hipertrofia ventricular izquierda (HVI) define a un grupo de enfermos con alto riesgo de presentar complicaciones y, entre ellos, los adolescentes son también vulnerables. El objetivo de esta investigación fue detectar precozmente la presencia de HVI en adolescentes hipertensos para orientar el tratamiento y reducir las complicaciones.

Material y método

Se llevó a cabo un estudio de intervención, cuasiexperimental, longitudinal, prospectivo en 572 adolescentes hipertensos. Se realizó ecocardiograma al inicio de la investigación y se ajustó el tratamiento médico para comparar al año los resultados.

Resultados

Predominó el sexo masculino (73,3%) y el color de la piel negra (63,6%). El mayor porcentaje de pacientes (53,0%) presentaba HTA moderada. Sólo el 5,9 % de ellos aplicaba correctamente las medidas higiénico-dietéticas y las estrategias farmacológicas estaban subutilizadas. Al inicio del estudio, el 73,6% de los pacientes llevaban un tratamiento irregular y no lograban controlar su tensión arterial. Al año habíamos logrado controlar al 92% de los enfermos, se redujo la HVI y se mejoró la disfunción diastólica.

Conclusiones

Encontramos un gran número de adolescentes con HTA no controlada y muchos de ellos presentaban HVI (27,1 %) y alteraciones de la función diastólica (30,2%). Con el tratamiento adecuado logramos mejorar o normalizar dichas afecciones y logramos, además, controlar la tensión arterial. Mucho tienen que continuar haciendo los trabajadores de la Atención Primaria, pero el apoyo de la atención secundaria es vital para lograr los objetivos deseados.

Palabras clave:
hipertensión arterial
adolescencia
hipertrofia ventricular izquierda
diagnóstico
Introduction

Arterial hypertension (AHT) is a worldwide health problem and its risk depends on whether the organ can be harmed. Left ventricular hypertrophy (LVH) defines a group of patients at high risk of having complications and adolescents are also vulnerable. This research aimed to detect the presence of LVH early in hypertensive adolescents to orient treatment and reduce complications.

Material and methods

An intervention, quasi-experimental, longitudinal, prospective study was conducted in 572 hypertensive adolescents. An echocardiogram was performed at the onset of the investigation and the medical treatment was adjusted at one year to compare the results.

Results

There was predominance of male gender (73.3%) and black skin (63.6%). The largest percent of patients (53.0%) had moderate AHT. Only 5.9% of them correctly used hygienic-dietary measures and drug strategies were underused. At the onset of the study, 73.6 % of the patients had irregular treatment and did not achieve blood pressure control. At one year, we had achieved control in 92% of the patients, LVH was reduced and diastolic dysfunction improved.

Conclusions

We found a large number of adolescents with uncontrolled AHT and many had LVH (27.1%) and diastolic function alterations (30.2 %). With adequate treatment, we were able to improve or normalized these conditions and also achieved a control of blood pressure. The primary health care workers must continue working very much, however the support of secondary care is essential to achieve the objectives desired.

Key words:
arterial hypertension
adolescence
left ventricular hypertrophy
diagnosis
PDF

Artículo

Opciones para acceder a los textos completos de la publicación Hipertensión y Riesgo Vascular
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Bibliografía
[1.]
G. Gazzara, I. Álvarez, M.C. Barrenechea, I. Basso, M. Bernadá, S. Bonelli, et al.
Hipertensión arterial en el niño y el adolescente.
Arch Pediatr Urug, 73 (2002), pp. 26-31
[2.]
Saieh C. Hipertensión arterial en la infancia y la adolescencia. [Artículo en internet]. [Consultado 10/06/2005]. Disponible en; http://www2.udec.cl/~ofem/revista/revista05/artic3.htm
[3.]
A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo, et al.
and the National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Hypertension, 42 (2003), pp. 1206-1252
[4.]
L.B. Goldstein, R. Adams, K. Becker, C.D. Furberg, P.B. Gorelick, G. Hademenos, et al.
Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association.
Circulation, 103 (2001), pp. 163-182
[5.]
I. Hajjar, T.A. Kotchen.
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000.
JAMA, 290 (2003), pp. 199-206
[6.]
Schena RA, Forcada P, Gozza J, Schena RG. La respuesta presora al stress físico en adolescentes y jóvenes puede ser un marcador primario de hipertensión arterial. Foro de Cardiología del ejercicio. [Artículo en internet]. [Consultado 10/06/2005]. Disponible en; http://www.fac.org.ar/fec/foros/ exercise/docs/schena01.htm
[7.]
D.W. Jones, L.J. Appel, S.G. Sheps, E.J. Roccella, C. Lenfant.
Measuring blood pressure accurately: new and persistent challenges.
JAMA, 289 (2003), pp. 1027-1030
[8.]
National High Blood Pressure Education Program Working Group on High Blood Pressure in ChildrenAdolescents. The Fourth Report on the Diagnosis Evaluation,Treatment of High Blood Pressure in ChildrenAdolescents.
Pediatrics, 114 (2004), pp. 555-576
[9.]
P.M. Okin, J.T. Wright, M.S. Nieminen, S. Jern, A.L. Taylor, R. Phillips, et al.
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. For the LIFE Study Investigators.
Am J Hypertens, 15 (2002), pp. 663-671
[10.]
R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, I. Sachs, et al.
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.
Am J Cardiol, 57 (1986), pp. 450-458
[11.]
Daniels, SR, T.R. Kimball, J.A. Morrison, P. Khoury, S. Witt, R.A. Meyer.
Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents. Statistical, biological, and clinical significance.
Circulation, 92 (1995), pp. 3249-3254
[12.]
D.J. Sahn, A. DeMaria, J. Kisslo, A. Weyman.
Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
Circulation, 58 (1978), pp. 1072-1083
[13.]
R.B. Devereux.
Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization and comparison to other methods.
Hypertension, 9 (1987), pp. 19-20
[14.]
S.R. Daniels, R.A. Meyer, J.M.H. Loggie.
Determinants of cardiac involvement in children and adolescents with essential hypertension.
Circulation, 82 (1990), pp. 1243-1248
[15.]
S.R. Daniels, R.A. Meyer, Y. Liang, K.E. Bove.
Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults.
J Am Coll Cardiol, 12 (1988), pp. 703-708
[16.]
J. McMurray, J. Ostergren, M. Pfeffer, K. Swedberg, C. Granger, S. Yusuf, et al.
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) programme.
Eur J Heart Fail, 5 (2003), pp. 261-270
[17.]
B.M. Psaty, T. Lumley, C.D. Furberg, G. Schellenbaum, M. Pahor, M.H. Alderman, et al.
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
JAMA, 289 (2003), pp. 2534-2544
[18.]
The ALLHAT OfficersCoordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the AntihypertensiveLipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
JAMA, 288 (2002), pp. 2981-2997
[19.]
M.R. Law, N.J. Wald, J.K. Morris, R.E. Jordan.
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.
BMJ, 326 (2003), pp. 1427-1434
[20.]
R.M. Cooper-DeHoff, H.A. Bristol, C.J. Pepine.
Ethnic differences in systolic blood pressure control in hypertensive patients with coronary artery disease.
Am J Hypertens, 16 (2003), pp. 27A
[21.]
J.G. Douglas, G.L. Bakris, M. Epstein, K.C. Ferdinand, C. Ferrario, J.M. Flack, et al.
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.
Arch Intern Med, 163 (2003), pp. 525-541
[22.]
Lurbe E, Torró I, Cremades B. Hipertensión arterial en niños y adolescentes. Protocolos diagnósticos y terapéuticos en pediatría. [On line]. [Consultado 22/07/2006]. p 155-164.Disponible en; http://www.aeped.es/protocolos/nefro/13-hipertension- arterial.pdf
[23.]
Ulate GA. Valores de presión arterial en una muestra de niños y adolescentes del valle central de Costa Rica. Acta Médica Costarr 1989; 33(2). [On line]. [Consultado 20/06/2006]. Disponible en; http://www.binasss.sa.cr/adolescencia/ presionarterial.htm
[24.]
M.S. Bahrke, C.E. Yesalis, A.N. Kopstein, J.A. Stephens.
Risk factors associated with anabolic-androgenic steroid use among adolescents.
Sports Med, 29 (2000), pp. 397-405
[25.]
A.B. Parkinson, N.A. Evans.
Anabolic androgenic steroids: a survey of 500 users.
Med Sci Sports Exerc, 38 (2006), pp. 644-651
[26.]
P.J. Perry, B.C. Lund, M.J. Deninger, E.C. Kutscher, J. Schneider.
Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization.
Clin J Sport Med, 15 (2005), pp. 326-330
[27.]
E. Roccella, N. Kaplan.
Interpretation and evaluation of clinical guidelines.
Hypertension primer: the essentials of high blood pressure: basic science, population science, and clinical management, pp. 126-127
[28.]
S. Lewington, R. Clarke, N. Qizilbash, R. Peto, R. Collins.
Agespecific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Prospective Studies Collaboration.
Lancet, 360 (2002), pp. 1903-1913
[29.]
F.L. Moreno Martínez, O.J. López Bernal, R.J. Llanes Pelegrín, S. Cepero Franco, N. Rodríguez Oliva.
Obesidad: aspectos patogénicos, alteraciones cardiovasculares asociadas y estrategias terapéuticas.
Mapfre Medicina, 16 (2005), pp. 209-222
[30.]
R.S. Vasan, M.G. Larson, E.P. Leip, J.C. Evans, C.J. O’Donnell, W.B. Kannel, et al.
Impact of high-normal blood pressure on the risk of cardiovascular disease.
N Engl J Med, 345 (2001), pp. 1291-1297
[31.]
S.S. Franklin, M.G. Larson, S.A. Khan, N.D. Wong, E.P. Leip, W.B. Kannel, et al.
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study.
Circulation, 103 (2001), pp. 1245-1249
[32.]
R.P. Lifton, A.G. Gharavi, D.S. Geller.
Molecular mechanisms of human hypertension.
Cell, 104 (2001), pp. 545-556
[33.]
S.P. Whelton, A. Chin, X. Xin, J. He.
Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials.
Ann Intern Med, 136 (2002), pp. 493-503
[34.]
S. Izumo, B. Nadal-Ginard, V. Mahdavi.
Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload.
Proc Natl Acad Sci, 85 (1988), pp. 339-343
[35.]
J. He, P.K. Whelton, L.J. Appel, J. Charleston, M.J. Klag.
Longterm effects of weight loss and dietary sodium reduction on incidence of hypertension.
Hypertension, 35 (2000), pp. 544-549
[36.]
L.J. Appel, C.M. Champagne, D.W. Harsha, L.S. Cooper, E. Obarzanek, P.J. Elmer, et al.
Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. Writing Group of the PREMIER Collaborative Research Group.
JAMA, 289 (2003), pp. 2083-2093
[37.]
R.S. Strauss, H.A. Pollack.
Epidemic increase in childhood overweight, 1986-1998.
JAMA, 286 (2001), pp. 2845-2848
[38.]
P.A. Barrier, J.T. Li, N.M. Jensen.
Two words to improve physician- patient communication: what else?.
Mayo Clin Proc, 78 (2003), pp. 211-214
[39.]
S.K. Maue, M.L. Rivo, B. Weiss, E.W. Farrelly, S. Brower-Stenger.
Effect of a primary care physician-focused, population-based approach to blood pressure control.
Fam Med, 34 (2002), pp. 508-513
[40.]
D.J. Hyman, V.N. Pavlik, C. Vallbona.
Physician role in lack of awareness and control of hypertension.
J Clin Hypertens, 2 (2000), pp. 324-330
[41.]
S.C. Shih, J.E. Bost, L.G. Pawlson.
Standardized health plan reporting in four areas of preventive health care.
Am J Prev Med, 24 (2003), pp. 293-300
asdasdasd
Opciones de artículo
Herramientas